Drug Delivery Systems
What are Drug Delivery Systems?
The term "drug delivery systems" refers to both the construct of the drug – its delivery vehicle – and its method of administration.
New Drug Delivery Vehicles
Some of the major vehicles being researched for delivering drugs are:
The main focus of this document will be on the new drug delivery vehicles.
The Science – How do Drug Delivery Systems Work?
Liposomes
Liposomes encapsulate active drugs to improve their delivery. With liposomes, the active drug is carried within its layers or in the hallow space in the middle of the liposome. The immune system, which seeks out foreign material for destruction, can be a major obstacle to liposomes. In 1992, researchers discovered that coating liposomes with inactive polymers, such as polyethylene glycol (PEG), drastically increased the liposome's ability to evade recognition by the immune system.
The main mechanism of a liposome is simply fusing to the cell membrane or through endocytosis.
Polymers are made in different shapes and sizes. They can come in a rod-like shape, with the drug attached to it, or be circular with the drug inside the polymer construct. They can also be biodegradable or non-biodegradable. Biodegradable polymers like PLA and PLGA are commonly used since they do not have to be surgically removed from the body after the drug is released.
Polymers can deliver drugs through dissolution, diffusion, or osmosis.
In dissolution, the drug is released over time as the polymer dissolves in the gastrointestinal tract. Mixing and layering polymers with varying dissolutions rates controls the rate of release.In diffusion, the release of the drug is controlled by its rate of diffusion out of the polymer.In osmosis, the drug is contained in a polymer consisting of two compartments: one compartment contains the drug and the other contains a biologically inactive agent that can push out the drug under certain conditions – a push layer. When an individual takes the drug in pill form, water penetrates the pill through the membrane of the polymer. This step activates the push layer, which then drives the active ingredient into the gastrointestinal tract through one or more tiny holes on the other side of the pill.
Upon swallowing, the biologically inactive parts of the pill remain intact during its voyage through the gastrointestinal tract and are eliminated in the feces as an insoluble shell.
Biotechnology Drug Delivery Systems
Biotechnology is improving the mechanism of two drug delivery vehicles called liposomes and polymers.
Liposomes are fatty droplets made artificially in the lab by the addition of a water solution to a phospholipid gel. Liposomes encapsulate active drugs to improve their delivery. Depending on the construction of the liposome, the active drug can be carried within its layers or in the hallow space created by the encapsulation. Liposomes mimic the natural phospholipid cell membranes in the human body.
Liposomes are currently being used for intravenous delivery of small molecules and are being investigated for oral, transdermal (through skin), and sustained-release delivery of drugs. Liposomes are often attached to other molecules, like polyethylene glycol (PEG), that will prevent or lessen detection by the immune system.
Polymers
Polymers are formed by the linkage of a large number of smaller molecules, called monomers. Natural polymers include proteins, DNA, and latexes, such as rubber. Synthetic polymers include glass, concrete and plastics. The polymers used to deliver drugs are usually lactic acid based, such as polylactic acid (PLA) and polylactic-co-glycolic acid (PLGA).
Lactic acid is a compound that is naturally produced when glucose is metabolized in the body. PLA and PLGA have been used as bioabsorbable sutures for more than 20 years, so their safety is well established.
Polymers can be designed to either release a drug at a steady rate for a long time, or it can release the drug after a prolonged interval. Polymers can also be attached to antibodies to deliver drugs to a specific target.
Biotechnology is contributing to advances in drug delivery through gene and protein discovery, and the resulting knowledge of human biological systems. This allows researchers to create synthetic systems that mimic the already existing biological processes in the body. Also, as researchers learn more about certain diseases, they can discover drug delivery targets that are more specific to the particular disease.
The current development of delivery systems as well as methods of administration are the result of chemical, technical, and biological advances and the subsequent understanding of the body.
Drug Delivery Systems in Development
The next step in drug delivery will be the creation of vehicles or constructs that can target the disease tissue more accurately. There are several developments currently underway:
Smart Drugs – Also known as "prodrugs," these compounds are designed to work only when activated by certain components in the body. For example, a smart drug designed to be activated by a certain enzyme will be activated only in tissues that produces that specific enzyme.
Monoclonal Antibodies – These are antibodies made in the lab that can target antigens with extreme specificity. They are attached to a drug in order to guide it to a specific cell. For example, cancer drugs can be attached to monoclonal antibodies made against tumour cells, which helps the drug target only tumour cells. This reduces the toxic effects of cancer drugs. How do Monoclonal Antibodies Work?
Polymer, definition. Xrefer.com 9 July 2001.
Polymer, definition. Academic Press Dictionary of Science and Technology. 25 July 2001.
Chaubal, Mahesh. "Controlled Release Technologies: Current Status and Future Potential." June 11, 2001 Spectrum Life Sciences, Decision Resources Inc.
Lasic, Dan and Brian keller. "Outlook for Novel Lipid-Based Drug Delivery Systems." 15 June 2001. Spectrum Life Sciences, Decision Resources Inc.
Farr-Jones, Shauna. "Delivery Technologies for Therapeutic Proteins." 17 November 2001. Spectrum Life Sciences, Decision Resources Inc.
Stealth Liposomal Technology. Alza Corporation. <www.alza.com 28 July 2001.
Liposomes: Formulation, Methods of Manufacture and evaluation. 9 July 2001. <members.tripod.com/`rkrishna/basics1.>
New Drug Delivery Systems Offers More Options. <www.mercola.com/2000/apr/9/new_drug_delivery_systems.> 9 July 2001.
Brannon-Peppas, Lisa. "Polymers in Controlled Drug Delivery." November 1997 Medical Device Link <www.devicelink.com/grabber...ink.com/mpb/archive/97/11/003.> 9 July 2001.
Kefalides, Paul T. "New Methods for Drug Delivery." Annals of Internal Medicine June 15, 1998 <www.acponline.org/journals/annals/15jun98/currdrug.> 9 July 2001.
Polymeric Drug Delivery – A Brief Review. <www.drugdel.com 28 July 2001. Steinberg, Fredric Murry and Jack Raso. "Biotech Pharmaceuticals and Biotherapy." American Council on Science and Health: May 1998